Nocturnal enuresis: medical management

Urol Clin North Am. 2004 Aug;31(3):491-8, ix. doi: 10.1016/j.ucl.2004.04.007.

Abstract

Nocturnal enuresis is a problem that affects many children and their families. The etiology seems to be multifactorial and may include a combination of genetic factors,abnormal urodynamics, alterations in vasopressin secretion, sleep factors, psychologic factors, organic disease, and maturational delay. Generally, a complete history and physical examination, with a specific focus on the genitourinary, gastrointestinal, and neurologic systems, is all is that is needed in the evaluation of a patient with enuresis.Currently, the mainstays of medical therapy are DDAVP, imipramine, and oxybutynin. Medications can help to control the symptoms of enuresis, but they generally do not provide a cure; therefore, behavioral therapy is often recommended in conjunction with pharmacotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antidepressive Agents, Tricyclic / therapeutic use
  • Deamino Arginine Vasopressin / therapeutic use
  • Enuresis / physiopathology
  • Enuresis / psychology
  • Enuresis / therapy*
  • Humans
  • Imipramine / therapeutic use
  • Mandelic Acids / therapeutic use
  • Physical Examination
  • Renal Agents / therapeutic use
  • Urodynamics

Substances

  • Antidepressive Agents, Tricyclic
  • Mandelic Acids
  • Renal Agents
  • Deamino Arginine Vasopressin
  • oxybutynin
  • Imipramine